Workflow
MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business
MYNDMynd(MYND) Newsfile· Newsfile·2024-11-13 01:05
          MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on businessNovember 12, 2024 8:05 PM EST | Source: MYND Life Sciences Inc.Vancouver, British Columbia--(Newsfile Corp. - November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the development and commercialization of a biomarker tool for monitoring depression, today announced that subject to regulatory approval,  ...